University Hospital of Heidelberg
Heidelberg, Baden-Würtemberg, 69120, Germany
NCT Number: NCT01100710
The purpose of this study is to determine the influence of functional or anatomic cardiac parameters, age and gender on high sensitivity cTnT (TnThs) levels in healthy individuals.
Looking for future studies?
Notify Me20 year–70 year
All sexes
Observational
Heidelberg, Baden-Würtemberg, 69120, Germany
We sought to investigate the relative contribution of functional or anatomic parameters as assessed by cardiac magnetic resonance tomography (cMRI, 1.5 Tesla), and clinical variables including increasing age and gender on high sensitivity cTnT (TnThs) levels in healthy individuals. Therefore we measured TnThs in serum samples of 120 healthy volunteers aged between 20 and 70 years. All individuals underwent cMRI including stress testing using dobutamine or adenosine.TnThs concentrations were related to cMRI and clinical findings. Partial correlation, as well as linear and hierarchical regression analyses were used to identify independent predictors and their relative contribution for prediction of TnThs values.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Looking for future studies?
Notify MeHeidelberg University
Other
Relative Contribution of Age, Gender and Left Ventricular Mass as Quantified by Cardiac Magnetic Resonance Tomography to Detectable Levels of Cardiac Troponin T in a Healthy Reference Population Aged Below 70 Years
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07833384
Arterial Occlusive Diseases, Arteriosclerosis
Baton Rouge, Louisiana, United States
View Trial DetailsNCT04591639
Cardiomyopathies, Cardiovascular Diseases
Edinburgh, Scotland, United Kingdom
View Trial DetailsNCT05696522
Arrhythmias, Cardiac, Cardiac Conduction System Disease
London, United Kingdom
View Trial DetailsNCT07390110
Cardiovascular Diseases, Diabetes Mellitus
Boston, Massachusetts, United States
View Trial Details